are being used to ensure INTEGRA Meshed Bilayer
Wound Matrix is in complete contact with the wound
When Used With Negative Pressure Therapy
- Utilize Negative Pressure Wound
Therapy Device according to manufaturers instructions
paying special attention to wound monitoring
Do not let Dakins Solution, petroleum-based
products, e.g., Xeroform, or enzymatic debridement agents,
(e.g., Collagenase), come in contact with the INTEGRA
Meshed Bilayer Wound Matrix application sites.
Use splints or bolsters, per unit protocols, during first
5-7 days. Splints should be applied and should stay on
at all times (except when performing wound care).
ADAPTIC is a trademark of Systagenix Wound Management
Mepitel is a registered trademark of Molnlycke Health